Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21

被引:0
|
作者
Jean-Louis Blouin
Beth A. Dombroski
Swapan K. Nath
Virginia K. Lasseter
Paula S. Wolyniec
Gerald Nestadt
Mary Thornquist
Gail Ullrich
John McGrath
Laura Kasch
Malgorzata Lamacz
Marion G. Thomas
Corinne Gehrig
Uppala Radhakrishna
Sarah E. Snyder
Katherine G. Balk
Karin Neufeld
Karen L. Swartz
Nicola DeMarchi
George N. Papadimitriou
Dimitris G. Dikeos
Costas N. Stefanis
Aravinda Chakravarti
Barton Childs
David E. Housman
Haig H. Kazazian
Stylianos E. Antonarakis
Ann E. Pulver
机构
[1] University of Geneva Medical School and Cantonal Hospital,Division of Medical Genetics
[2] University of Pennsylvania,Department of Genetics
[3] Case Western Reserve University and University Hospitals of Cleveland,Department of Genetics and Center for Human Genetics
[4] The Johns Hopkins School of Medicine,Department of Psychiatry and Behavioral Sciences
[5] Seconda Universita di Napoli,undefined
[6] Instituto di Psichiatria ,undefined
[7] University Mental Health Research Institute,undefined
[8] Eginition Hospital,undefined
来源
Nature Genetics | 1998年 / 20卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Schizophrenia is a common disorder characterized by psychotic symptoms; diagnostic criteria have been established1. Family, twin and adoption studies suggest that both genetic and environmental factors influence susceptibility (heritability is approximately 71%; ref. 2), however, little is known about the aetiology of schizophrenia. Clinical and family studies suggest aetiological heterogeneity3,6. Previously, we reported that regions on chromosomes 22, 3 and 8 may be associated with susceptibility to schizophrenia7,8, and collaborations provided some support for regions on chromosomes 8 and 22 (refs 9, 10, 11, 12, 13). We present here a genome-wide scan for schizophrenia susceptibility loci (SSL) using 452 microsatellite markers on 54 multiplex pedigrees. Non-parametric linkage (NPL) analysis provided significant evidence for an SSL on chromosome 13q32 (NPL score = 4.18; P = 0.00002), and suggestive evidence for another SSL on chromosome 8p21–22 (NPL = 3.64; P = 0.0001). Parametric linkage analysis provided additional support for these SSL. Linkage evidence at chromosome 8 is weaker than that at chromosome 13, so it is more probable that chromosome 8 may be a false positive linkage. Additional putative SSL were noted on chromosomes 14q13 (NPL = 2.57; P = 0.005), 7q11 (NPL = 2.50, P = 0.007) and 22q11 (NPL = 2.42, P = 0.009). Verification of suggestive SSL on chromosomes 13q and 8p was attempted in a follow-up sample of 51 multiplex pedigrees. This analysis confirmed the SSL in 13q14-q33 (NPL = 2.36, P = 0.007) and supported the SSL in 8p22-p21 (NPL = 1.95, P = 0.023).
引用
收藏
页码:70 / 73
页数:3
相关论文
共 50 条
  • [21] Evidence for a putative bipolar disorder locus on 2p13-16 and other potential loci on 4q31, 7q34, 8q13, 9q31, 10q21-24, 13q32, 14q21 and 17q11-12
    Liu, J
    Juo, SH
    Dewan, A
    Grunn, A
    Tong, X
    Brito, M
    Park, N
    Loth, JE
    Kanyas, K
    Lerer, B
    Endicott, J
    Penchaszadeh, G
    Knowles, JA
    Ott, J
    Gilliam, TC
    Baron, M
    MOLECULAR PSYCHIATRY, 2003, 8 (03) : 333 - 342
  • [22] Linkage of a bipolar disorder susceptibility locus to human chromosome 13q32 in a new pedigree series
    S H Shaw
    Z Mroczkowski-Parker
    T Shekhtman
    M Alexander
    R A Remick
    A D Sadovnick
    S L McElroy
    P E Keck
    J R Kelsoe
    Molecular Psychiatry, 2003, 8 : 558 - 564
  • [23] Evidence for interaction between psoriasis-susceptibility loci on chromosomes 6p21 and 1q21
    Capon, F
    Semprini, S
    Dallapiccola, B
    Novelli, G
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (06) : 1798 - 1800
  • [24] Rescue from the effects of trisomy 13q32→qter owing to skewed X inactivation in a der(X)t(X;13) (p21;q32) carrier
    Blennow, E
    Sahlén, S
    JOURNAL OF MEDICAL GENETICS, 1999, 36 (09) : 718 - 719
  • [25] An integrated transcript map of the chromosome 13q32 region linked to bipolar disorder and schizophrenia.
    Christian, SL
    Vlamakis, V
    Liu, CY
    Badner, JA
    Gershon, ES
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 272 - 272
  • [26] Fine mapping supports previous linkage evidence for a bipolar disorder susceptibility locus on 13q32
    Liu, CY
    Badner, JA
    Christian, SL
    Guroff, JJ
    Detera-Wadleigh, SD
    Gershon, ES
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 105 (04): : 375 - 380
  • [27] Linkage of a bipolar disorder susceptibility locus to human chromosome 13q32 in a new pedigree series
    Shaw, SH
    Mroczkowski-Parker, Z
    Shekhtman, T
    Alexander, M
    Remick, RA
    Sadovnick, AD
    McElroy, SL
    Keck, PE
    Kelsoe, JR
    MOLECULAR PSYCHIATRY, 2003, 8 (05) : 558 - 564
  • [28] Novel mutation and three other sequence variants segregating with phenotype at keratoconus 13q32 susceptibility locus
    Marta Czugala
    Justyna A Karolak
    Dorota M Nowak
    Piotr Polakowski
    Jose Pitarque
    Andrea Molinari
    Malgorzata Rydzanicz
    Bassem A Bejjani
    Beatrice Y J T Yue
    Jacek P Szaflik
    Marzena Gajecka
    European Journal of Human Genetics, 2012, 20 : 389 - 397
  • [29] Novel mutation and three other sequence variants segregating with phenotype at keratoconus 13q32 susceptibility locus
    Czugala, Marta
    Karolak, Justyna A.
    Nowak, Dorota M.
    Polakowski, Piotr
    Pitarque, Jose
    Molinari, Andrea
    Rydzanicz, Malgorzata
    Bejjani, Bassem A.
    Yue, Beatrice Y. J. T.
    Szaflik, Jacek P.
    Gajecka, Marzena
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2012, 20 (04) : 389 - 397
  • [30] Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23
    Gurling, HMD
    Kalsi, G
    Brynjolfson, J
    Sigmundsson, T
    Sherrington, R
    Mankoo, BS
    Read, T
    Murphy, P
    Blaveri, E
    McQuillin, A
    Petursson, H
    Curtis, D
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (03) : 661 - 673